1. Home
  2. EEA vs BTMD Comparison

EEA vs BTMD Comparison

Compare EEA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The European Equity Fund Inc.

EEA

The European Equity Fund Inc.

HOLD

Current Price

$11.04

Market Cap

73.5M

Sector

Finance

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.20

Market Cap

65.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEA
BTMD
Founded
1986
2012
Country
Germany
United States
Employees
N/A
223
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
65.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EEA
BTMD
Price
$11.04
$2.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
50.7K
408.6K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
722.22
EPS
N/A
0.06
Revenue
N/A
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$36.17
Revenue Growth
N/A
N/A
52 Week Low
$9.62
$1.27
52 Week High
$11.43
$4.75

Technical Indicators

Market Signals
Indicator
EEA
BTMD
Relative Strength Index (RSI) 61.34 53.04
Support Level $10.57 $1.97
Resistance Level $11.06 $2.17
Average True Range (ATR) 0.23 0.19
MACD 0.03 -0.03
Stochastic Oscillator 76.03 62.07

Price Performance

Historical Comparison
EEA
BTMD

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: